Table 3.
Diets (D) | Sampling Time (T) in Weeks | Effect * | |||||||
---|---|---|---|---|---|---|---|---|---|
Control | ActiSaf | SEM † | 3 | 6 | SEM † | D | T | DxT | |
Blood plasma | |||||||||
GST | 0.150 | 0.132 | 0.011 | 0.148 | 0.134 | 0.011 | 0.282 | 0.336 | 0.903 |
GR | 0.067 | 0.076 | 0.002 | 0.067 | 0.076 | 0.002 | 0.004 | 0.003 | 0.458 |
GSH-Px | 0.398 | 0.423 | 0.025 | 0.353 | 0.468 | 0.021 | 0.476 | 0.000 | 0.847 |
SOD | 18.544 | 20.304 | 0.987 | 18.409 | 20.440 | 1.170 | 0.227 | 0.301 | 0.427 |
CAT | 4.969 | 5.008 | 0.146 | 4.893 | 5.084 | 0.131 | 0.855 | 0.255 | 0.477 |
FRAP | 0.641 | 0.764 | 0.045 | 0.675 | 0.730 | 0.036 | 0.099 | 0.230 | 0.409 |
ABTS | 36.888 | 33.045 | 0.497 | 35.577 | 34.356 | 0.617 | 0.000 | 0.246 | 0.195 |
MDA | 0.601 | 0.566 | 0.067 | 0.604 | 0.562 | 0.055 | 0.729 | 0.497 | 0.304 |
PC | 4.065 | 4.015 | 0.085 | 3.886 | 4.193 | 0.110 | 0.685 | 0.114 | 0.981 |
Milk | |||||||||
LPO | 0.504 | 0.602 | 0.059 | 0.628 | 0.478 | 0.047 | 0.265 | 0.006 | 0.467 |
SOD | 3.677 | 3.569 | 0.173 | 3.577 | 3.669 | 0.157 | 0.664 | 0.660 | 0.859 |
CAT | 29.284 | 32.359 | 3.564 | 33.558 | 28.085 | 2.836 | 0.552 | 0.054 | 0.750 |
FRAP | 3.013 | 3.090 | 0.179 | 2.855 | 3.247 | 0.158 | 0.766 | 0.078 | 0.445 |
ABTS | 37.563 | 43.85 | 1.014 | 40.254 | 41.158 | 1.057 | 0.001 | 0.572 | 0.726 |
MDA | 0.363 | 0.369 | 0.018 | 0.363 | 0.369 | 0.015 | 0.843 | 0.693 | 0.687 |
PC | 2.916 | 2.877 | 0.106 | 2.925 | 2.867 | 0.108 | 0.801 | 0.718 | 0.541 |
† SEM = Standard error of the mean. GST: Glutathione transferase. GR: Glutathione reductase. SOD: Superoxide dismutase. GSH-Px: Glutathione peroxidase. CAT: Catalase. ABTS: 2,2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (inhibition%). FRAP: Ferric Reducing Ability of Plasma (μΜ ascorbic acid). MDA: Malondialdehyde (μΜ MDA). PCs: Protein carbonyls (nmol/mL). LPO: Lactoperoxidase. Significance level below 0.05 indicates significant difference. * Effect: The dietary treatment (D), time (T), and the interaction between dietary treatment × time (DxT) effects were analyzed by ANOVA using a general linear model (GLM) for repeated measures and posthoc analysis was performed when appropriate using Tukey’s multiple range test.